Sphinx Pharmaceuticals Corporation
Records under this name other than patents Sphinx Pharmaceuticals Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Sphinx Pharmaceuticals Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 5,141,957 | 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase C Term ended Term ended no later than Aug 25, 2012 · Low confidence | Term ended | Term ended no later than Aug 25, 2012 | Low confidence |
| US 5,204,370 | Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase C Term ended Term ended no later than Apr 20, 2013 · Low confidence | Term ended | Term ended no later than Apr 20, 2013 | Low confidence |
| US 5,216,014 | Furo-coumarinsulfonamides as protein kinase C inhibitors Term ended Term ended no later than Jun 1, 2013 · Low confidence | Term ended | Term ended no later than Jun 1, 2013 | Low confidence |
| US 5,270,310 | N-aminoalkyl amide inhibitors of protein kinase C Formerly held Term ended Term ended no later than Dec 14, 2013 · Low confidence | Term ended | Term ended no later than Dec 14, 2013 | Low confidence |
| US 5,292,737 | N,N'-bis(sulfonamido)-2-amino-4-iminonaphthalen-1-ones and N,N'-bis(amido)-2-amino-4-iminonaphthalen-1-ones Term ended Term ended no later than Mar 8, 2014 · Low confidence | Term ended | Term ended no later than Mar 8, 2014 | Low confidence |
| US 5,344,841 | Bis-(hydroxylakylamino)-anthraquinone inhibitors of protein kinase C Term ended Term ended no later than Sep 6, 2014 · Low confidence | Term ended | Term ended no later than Sep 6, 2014 | Low confidence |
| US 5,360,818 | 1,3-dioxane derivatives having protein kinase C inhibitory activity Term ended Term ended no later than Nov 1, 2014 · Low confidence | Term ended | Term ended no later than Nov 1, 2014 | Low confidence |
| US 5,369,030 | Method of inducing cellular differentiations and altering cell phenotype using ceramide analogs Term ended Term ended no later than Nov 29, 2014 · Low confidence | Term ended | Term ended no later than Nov 29, 2014 | Low confidence |
| US 5,432,198 | Vicinal-substituted carbocyclic compounds as therapeutic agents Term ended Term ended no later than Jul 11, 2015 · Low confidence | Term ended | Term ended no later than Jul 11, 2015 | Low confidence |
| US 5,436,243 | Aminoanthraquinone derivatives to combat multidrug resistance Formerly held Term ended Term ended no later than Jul 25, 2015 · Low confidence | Term ended | Term ended no later than Jul 25, 2015 | Low confidence |